$1.35
Syndopa CR 250mg combines levodopa with carbidopa in a controlled-release formulation prescribed for Parkinson’s disease.
Designed around Levodopa and Carbidopa, Syndopa CR 250mg provides a controlled-release oral option for Parkinson’s disease treatment. Levodopa replenishes dopamine availability within the brain, while carbidopa reduces peripheral conversion before levodopa reaches the central nervous system.
$1.35
Syndopa CR 250mg combines levodopa with carbidopa in a controlled-release formulation prescribed for Parkinson’s disease.
Designed around Levodopa and Carbidopa, Syndopa CR 250mg provides a controlled-release oral option for Parkinson’s disease treatment. Levodopa replenishes dopamine availability within the brain, while carbidopa reduces peripheral conversion before levodopa reaches the central nervous system.
There are no reviews yet.
$1.35
Syndopa CR 250mg combines levodopa with carbidopa in a controlled-release formulation prescribed for Parkinson’s disease.
Designed around Levodopa and Carbidopa, Syndopa CR 250mg provides a controlled-release oral option for Parkinson’s disease treatment. Levodopa replenishes dopamine availability within the brain, while carbidopa reduces peripheral conversion before levodopa reaches the central nervous system.
There are no reviews yet.
Reviews
There are no reviews yet.